In support of this premise, somatic BRAF mutation, the molecular genetic hallmark of SSA/P, is relatively rare in CRC from young adults, being present at (3/45) 7% in a Norwegian study [16], 1/68 (2%) in a Spanish report [8], and in 0/39 (0%) from France [14]. This evidence concerns the gene BRAF and colorectal carcinoma.